← caffeine 65 mg

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

caffeine 65 mg

Central Nervous System Stimulant [EPC], Methylxanthine [EPC]

Prepared 24 Sep 2026

What it is used for

Use helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness Clinical selection for caffeine 65 mg should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Central Nervous System Stimulant [EPC], Methylxanthine [EPC]. Confirm site-specific dose, duration and monitoring before prescribing.

Warnings

Warnings For occasional use only Caffeine warning: The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heart beat. Do not use for children under 12 years of age as a substitute for sleep Stop use and ask a doctor if fatigue or drowsiness persists or continues to recur. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Possible side effects

Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage